Global Patent Index - EP 0918875 A1

EP 0918875 A1 19990602 - NOVEL INTERNAL RIBOSOME ENTRY SITE AND VECTOR CONTAINING SAME

Title (en)

NOVEL INTERNAL RIBOSOME ENTRY SITE AND VECTOR CONTAINING SAME

Title (de)

NEUE INTERNE RIBOSOMENZUGANGSSTELLE UND DIESE BEINHALTENDER VEKTOR

Title (fr)

NOUVEAU SITE INTERNE D'ENTREE DES RIBOSOMES ET VECTEUR LE CONTENANT

Publication

EP 0918875 A1 19990602 (FR)

Application

EP 98922883 A 19980428

Priority

  • FR 9800849 W 19980428
  • FR 9705203 A 19970428

Abstract (en)

[origin: FR2762615A1] The invention concerns the use of a nucleotide sequence derived from all or part of the genomic RNA 5' end of a type C retrovirus except for Friend murine leukaemia virus (FMLV) and Moloney murine leukaemia virus (MoMLV) as internal ribosome entry site or as element enabling or improving retrovirus vector packaging. The invention also concerns a vector comprising said nucleotide sequence, a viral particle generated from this vector, a cell comprising this vector or infected by the viral particle, their therapeutic use and a pharmaceutical composition containing them. The invention further concerns the use of a vector, a viral particle or a pharmaceutical composition for transfecting or infecting pluripotent stem cells.

IPC 1-7

C12N 15/86; C12N 15/11

IPC 8 full level

A61K 35/76 (2006.01); A61K 38/00 (2006.01); A61K 38/21 (2006.01); A61K 38/28 (2006.01); A61K 38/43 (2006.01); A61K 48/00 (2006.01); A61P 7/04 (2006.01); A61P 9/00 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 21/00 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 33/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 7/00 (2006.01); C12N 15/09 (2006.01); C12N 15/867 (2006.01)

CPC (source: EP US)

A61P 7/04 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 33/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C12N 15/86 (2013.01 - EP US); A61K 48/00 (2013.01 - EP US); C12N 2740/13052 (2013.01 - EP US); C12N 2840/203 (2013.01 - EP US); C12N 2840/206 (2013.01 - EP US); C12N 2840/55 (2013.01 - EP US)

Citation (search report)

See references of WO 9849334A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

FR 2762615 A1 19981030; FR 2762615 B1 19990716; AU 749250 B2 20020620; AU 7536598 A 19981124; CA 2258490 A1 19981105; EP 0918875 A1 19990602; JP 2001500021 A 20010109; US 6783977 B1 20040831; WO 9849334 A1 19981105

DOCDB simple family (application)

FR 9705203 A 19970428; AU 7536598 A 19980428; CA 2258490 A 19980428; EP 98922883 A 19980428; FR 9800849 W 19980428; JP 54667298 A 19980428; US 21412499 A 19990317